GSE174380
Latent HIV infection disrupts cell-intrinsic innate immunity
Bulk RNA Sequencing of Jurkat E6-1 & JLat9.2 CD4+ T cells Treated with 100IU/mL IFNb Overall design: Jurkat E6-1 & JLat9.2 CD4+ T cells were treated with 100IU/mL IFNb and sampled at 4 hours, 8 hours, and 12 hours post-treatment. An untreated "Mock" group for both Jurkat E6-1 & JLat9.2 CD4+ T cells were sampled at 4 hours.